Publication | Closed Access

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Surgical OncologyPhase Ii TrialMedicineMetronomic TherapyPathologyLiposomal DoxorubicinMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyVersus Doxorubicin